Wadih A. C.
- Country
- France
- Department
- Hématologie pédiatrique
Research Overview
- Phase III Open‑Label Study of Subcutaneous Benralizumab in Children with Eosinophilic Disease: Safety, PK/PD, Efficacy and Immunogenicity
- ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) with Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
- Evaluation of Pegaspargase Efficacy and Tolerance in Pediatric Acute Lymphoblastic Leukemia Stratified by Risk and Immunophenotype
Data & Insights
Has run more than one trial at 26 of 107 partner sites.
Specializations
Hematologic Oncology
Specializes in the investigation of novel therapeutic approaches for acute lymphoblastic leukaemia, with particular emphasis on treatment strategies for patients ranging from infants to young adults aged 45 years.
- Pediatric Leukemia Treatment
- Young Adult Cancer Therapy
- Immunotherapy Applications
Focuses on developing integrated treatment protocols that aim to enhance survival rates while maintaining quality of life considerations.
Age-Specific Oncology
Concentrates on tailoring therapeutic interventions for distinct age groups affected by blood cancers, with specialized protocols designed for different developmental stages.
- Infant Cancer Treatment
- Childhood Cancer Protocols
- Adolescent Oncology
Explores age-adapted treatment strategies that account for specific biological and developmental characteristics of each age group.
Therapeutic Innovation
Engages in advancing treatment methodologies through targeted immunotherapy approaches and randomized interventional studies.
- Novel Treatment Protocols
- Survival Outcome Analysis
- Treatment Response Assessment
Evaluates innovative therapeutic interventions against established control populations to determine optimal treatment strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.